We just covered the
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. Natera, Inc. (NASDAQ:NTRA) ranks #1 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller).
Natera (NASDAQ:NTRA) develops genetic testing products used mainly in cancer detection, pregnancy screening, and organ health monitoring. Its key product is Signatera, a cancer testing platform that helps doctors monitor cancer recurrence.
Natera (NASDAQ:NTRA) says about 50% of oncologists are already ordering Signatera. In Q1, revenue rose about 38% year over year while test volumes jumped 18.5% year over year.
Some notable news for the stock includes FDA approvals like Signatera for bladder cancer, expanding Medicare reimbursement coverage, increasing adoption in international markets like **** an and expansion via acquisitions ( Foresight Diagnostics).
10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. Natera, Inc. (NASDAQ:NTRA) ranks #1 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller).
Natera (NASDAQ:NTRA) develops genetic testing products used mainly in cancer detection, pregnancy screening, and organ health monitoring. Its key product is Signatera, a cancer testing platform that helps doctors monitor cancer recurrence.
Natera (NASDAQ:NTRA) says about 50% of oncologists are already ordering Signatera. In Q1, revenue rose about 38% year over year while test volumes jumped 18.5% year over year.
Some notable news for the stock includes FDA approvals like Signatera for bladder cancer, expanding Medicare reimbursement coverage, increasing adoption in international markets like **** an and expansion via acquisitions ( Foresight Diagnostics).
5 months ago
